Back to list

Summit Partners

Summit Partners LLP is a private equity and venture capital firm specializing in later stage, mezzanine debt, growth capital, middle market, recapitalizations, possession financing, shareholder liquidity, management buyouts, bridge loans, acquisition financing, spin-off transactions, distressed situations/debtor-in-possession financing, and divestitures in fintech sector. It invests across all industry categories with a focus on education, technology enabled oilfield product and services, software, communications technology and services, semiconductors and electronics, gaming, leisure, Internet and information services, e-commerce, energy, media and entertainment, business services, financial technology and services, healthcare and life sciences, mobile, telecommunications, industrial products, consumer products, and other growth industries. The firm also invests in healthcare information technology, healthcare services, aerospace/defense, healthcare providers, healthcare services and healthcare technology, digital media, optical storage system, development tools, infrastructure services, and website infrastructure software. The firm prefers to invest in private companies around the world, focusing on Africa, North America with a focus on the United States; South America, Europe, Brazil, Asia focusing on South-East Asia, Australia and India. The firm seeks to invest between $2 million and $800 million in total in its portfolio companies. It seeks to make private equity investments between $30 million and $500 million; venture capital investments between $5 million and $30 million; and mezzanine debt financing of up to $125 million in conjunction with equity investment. In India, it seeks to invest $10 million to $100 million per company. The firm typically invests between $5 million and in excess of $500 million per company in combination of equity, subordinated debt, and senior debt financing. It prefers to be a lead or sole investor and can take a minority ownership position or controlling majority stake in its investee companies. The firm seeks to take a board seat and prefers to be a first institutional investor in its portfolio companies. Summit Partners was founded in 1984 and is based in Boston, Massachusetts with additional offices in Menlo Park, California; Palo Alto, California; Mumbai, India; and London, United Kingdom.

Donald Allen

Director of Portfolio Technology

JA

Jeffrey Allen

Associate

Matthias G. Allgaier

MD

DK

Dessi K. Andreeva

Manager of General Partner Financial Reporting

AA

Aleksandra Antolak

Associate

David W. Averett

MD

Gregory Avis

Cofounder and Senior Advisor

Susan Barr

VP of Marketing

Darren Black

MD

Chris Bon

VP

Adam D. Britt

MD

BB

Blake Brown

Associate

Gabriel Carreiro

VP

John Carroll

MD

Grace Chen

Associate

HC

Hanyin Cheng

VP

Peter Chung

MD and CEO

Eunji Chung

VP

Antony C. Clavel

MD

Andrew J. Collins

MD

Scott Collins

MD and COO

Andrea Costantino

VP

Kevin R. Curtin

Associate

Luna Dai

VP

Mark DeLaar

MD

Christopher Dean

MD

Robin Winters Devereux

MD and CAO

MR

Margaret Riley Devine

Chief Marketing Officer

AD

Ali Dowd

VP

Shaun Dunlop

Associate

KA

Kelly A. Echavarria

Associate

Bruce Evans

Investor

Harry Fackelmayer

Associate

Robert Fee

vice_president

Scott Ferguson

Principal

Leonard Ferrington

MD

CJ

Charles J. Fitzgerald

MD

Craig Frances

MD

Peter A. Francis

MD

Paul G. Furer

Principal

Richard J. Gentile

Associate

JH

Jonathan H. Gilman

Associate

Greg Goldfarb

MD

JG

John Gonneville

Associate

Johannes N. Grefe

MD

TW

Thomas W. Guilfoile

Associate

AJ

Angela J. Ha

Associate

Matthew G. Hamilton

MD

William W. Harrison

Associate

Robert M. Hassell

MD

MH

Mats Heimes

VP

Adam Hennessey

MD and CFO

AH

Andrew Hilboldt

Associate

MK

Madeline K. Hwang

Associate

KB

Kevin B. Jacobson

Associate

AS

Adesh S. Jain

VP

Thomas Jennings

MD

Brandon J. Kearse

Associate

Dennis H. Kim

Associate

JT

John T. Koo

Associate

Walter Kortschak

Managing Partner

Jesse Lane

Principal

AS

Andrew S. Lee

Associate

OG

Olivia G. Ley

Associate

MA

Michael A. Lukasek

VP of Finance

Martin Mannion

Investor

SM

Samuele Mazzoli

Associate

GM

Greg McDouglas

Associate

Michael A. Medici

MD

EP

Edward Patrick Meissner

VP and Corporate Controller

Harrison B. Miller

Senior Advisor

Colin T. Mistele

MD

Robert Mlnarik

Senior Associate

Sergio Mur

Principal

MR

Matthew R. Nash

Associate

PN

Peter Nielsen

Associate

Leslie A. Noonan

VP of Taxation

Mark T. Nordstrom

Principal

LN

Luke Nowicki

Associate

NO

Nik Ohri

Associate

Jono Pagden

vice_president

Nancy Parrish

Investor Relations Officer

Luke Parsons

VP

John W. Partridge

Partner

Jay D. Pauley

MD

Steffan K. Peyer

MD

AP

Alex Phelan

Associate

Sophia Popova

Principal

NP

Niclas Priess

Associate

Thomas Roberts

Managing Partner

CF

Catherine F. Rohr

Associate

Neil Roseman

Investor

IR

Ian Rothkopf

VP

Peter L. Rottier

MD

PD

Paul De Sadeleer

Associate

David Schiller

Chief Investor Relations Officer

DJ

Dean J. Serure

Associate

JT

Jessie T. Sheff

Associate

WS

William Sheldon

Senior Associate

J. Han K. J. Sikkens

MD and Head of Europe

Nicolas Slim

VP

E. Roe Stamps

Cofounder and Managing Partner

JJ

Jeffrey J. Stapleton

Associate

Ross D. Stern

MD

Christian Strain

MD

Thomas M. Tarnowski

MD